Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
5.49
+0.04 (0.73%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Atossa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 47 | 76 | 119 | 110 | 67 | 203 | |
| Market Cap Growth | -43.38% | -35.83% | 7.71% | 64.77% | -66.97% | 445.88% | |
| Enterprise Value | 6 | 24 | 44 | 17 | -50 | 63 | |
| Last Close Price | 5.49 | 8.85 | 14.16 | 13.20 | 7.93 | 24.00 | |
| PB Ratio | 1.20 | 1.94 | 1.66 | 1.21 | 0.57 | 1.47 | |
| P/TBV Ratio | 1.20 | 1.94 | 1.66 | 1.21 | 0.57 | 1.47 | |
| Net Debt / Equity Ratio | -1.05 | -1.05 | -0.99 | -0.97 | -0.94 | -0.99 | |
| Net Debt / EBITDA Ratio | 1.11 | 1.11 | 2.58 | 2.82 | 4.01 | 6.65 | |
| Net Debt / FCF Ratio | 1.39 | 1.39 | 3.38 | 4.22 | 5.34 | 8.28 | |
| Quick Ratio | 5.00 | 5.00 | 14.31 | 16.90 | 20.05 | 43.97 | |
| Current Ratio | 5.53 | 5.53 | 14.99 | 17.61 | 21.23 | 45.18 | |
| Return on Equity (ROE) | -62.74% | -62.74% | -31.39% | -28.80% | -21.05% | -24.93% | |
| Return on Assets (ROA) | -37.43% | -37.43% | -19.99% | -17.84% | -13.07% | -13.93% | |
| Return on Capital Employed (ROCE) | -94.40% | -94.40% | -38.60% | -34.50% | -23.50% | -14.90% | |
| Earnings Yield | -73.55% | -45.62% | -21.47% | -27.29% | -40.29% | -10.17% | |
| FCF Yield | -63.00% | -39.08% | -17.72% | -19.00% | -31.06% | -8.13% | |
| Buyback Yield / Dilution | -2.63% | -2.63% | 0.18% | 0.43% | -8.27% | -934.13% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.